These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4093345)

  • 21. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biliary pharmacokinetics of ticarcillin and clavulanic acid.
    Owen AW; Faragher EB
    J Antimicrob Chemother; 1986 May; 17 Suppl C():65-70. PubMed ID: 3722048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
    Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
    Chattopadhyay B; Hall I
    Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
    Leclercq R; Duval J
    Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticarcillin--clavulanic acid (Timentin).
    Med Lett Drugs Ther; 1985 Aug; 27(694):69-70. PubMed ID: 3894901
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacokinetics of clavulanic acid-potentiated ticarcillin in renal failure.
    Watson ID; Boulton-Jones M; Stewart MJ; Henderson I; Payton CD
    Ther Drug Monit; 1987 Jun; 9(2):139-47. PubMed ID: 3617151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of amoxycillin plus clavulanic acid and ticarcillin plus clavulanic acid compared with that of other antibiotics against anaerobic bacteria.
    Pierard D; De Meyer A; Rosseel P; Glupczynski Y; Struelens MJ; Delmee M; Pattyn SR; Verschraegen G; Melin P; Lauwers S
    Acta Clin Belg; 1989; 44(4):228-36. PubMed ID: 2618522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timentin in the treatment of post-operative infections.
    McLatchie GR; Williams S; Parameswaran S; Lindsay G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():189-94. PubMed ID: 3636333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
    Gould IM; Dent J; Wise R
    J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
    Branger C; Kitzis M; Le Mée J
    Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.
    Manian FA; Alford RH
    Antimicrob Agents Chemother; 1986 Jul; 30(1):35-8. PubMed ID: 3092732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prophylactic use of ticarcillin/clavulanate in the neonate.
    Fayed SB; Sutton AM; Turner TL; McAllister TA
    J Antimicrob Chemother; 1987 Jan; 19(1):113-8. PubMed ID: 3558165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical pharmacology and safety evaluation of Timentin.
    Jackson D; Cockburn A; Cooper DL; Langley PF; Tasker TC; White DJ
    Am J Med; 1985 Nov; 79(5B):44-55. PubMed ID: 4073095
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.